Written Exposure Therapy for Posttraumatic Stress Disorder

Description

Although evidence-based treatments for PTSD exist, a significant minority of individuals do not benefit from these treatments and many individuals to not seek treatment, citing barriers such as time commitment and expense of treatment. The goal of the proposed study is to establish an alternative PTSD treatment that is effective and efficient.

Study Start Date

February 2013

Estimated Completion Date

June 2017

Interventions

  • Behavioral: Cognitive Processing Therapy
  • Behavioral: Written Exposure Therapy

Specialties

  • Internal Medicine: Psychiatry
  • Psychiatry: Anxiety
  • Family Medicine: Psychiatry

MeSH Terms

  • Cognitive Processing Therapy
  • Posttraumatic Stress Disorder
  • Written Exposure Therapy

Study ID

Boston University -- H-31806

Status

Unknown

Trial ID

NCT01800773

Study Type

Interventional

Trial Phase

Phase 2

Enrollment Quota

126

Sponsor

Boston University

Inclusion Criteria

  • PTSD diagnosis
  • if taking psychotropic medication, on stable dose for 2 months
  • Ability to read and write in English

Exclusion Criteria

  • not currently engaged in active PTSD treatment
  • no current diagnosis of substance dependence
  • no current diagnosis of psychosis

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
National Center for PTSD at VA Boston Healthcare System - Boston, Massachusetts 5.4 miles Denise Sloan PhD 857-364-6333 denise.sloan@va.gov

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.